Results 191 to 200 of about 247,390 (257)

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes   +7 more
wiley   +1 more source

Targeted delivery of the CB2 receptor agonist JWH‐133 via VCAM‐1‐functionalised nanoparticles attenuates atherosclerosis and reveals sex‐specific therapeutic outcomes

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Atherosclerosis, a chronic inflammatory disease characterised by lipid accumulation and endothelial dysfunction, remains a leading cause of cardiovascular morbidity and mortality. While cannabinoid 2 (CB2) receptor agonists show therapeutic promise in preclinical studies, their systemic application is hindered by poor ...
Lucía Martín‐Navarro   +3 more
wiley   +1 more source

Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events. [PDF]

open access: yesCardiovasc Res
Fountas P   +13 more
europepmc   +1 more source

Cardiometabolic Protein Profile Changes During Gender‐Affirming Hormone Therapy: A Prospective Clinical Study

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Cardiovascular disease (CVD) risk is elevated in transgender individuals during gender‐affirming hormone therapy (GAHT) with expected different mechanisms between T‐ and E2‐based GAHT. We investigated prospective changes in cardiometabolic proteins relating to complement, inflammation, and transport during GAHT.
Emilie Bukh Madsen   +12 more
wiley   +1 more source

Integrated single-cell atlas of human atherosclerotic plaques. [PDF]

open access: yesNat Commun
Traeuble K   +8 more
europepmc   +1 more source

MD‐1 Deficiency Mitigates Atherosclerosis by Inhibiting NLRP3 Inflammasome Activation via cGAS‐STING Dependent Pathway in Macrophages

open access: yesCell Proliferation, EarlyView.
MD‐1 is induced and activated in macrophages. The activated MD‐1 subsequently promotes the cGAS‐STING‐TBK1‐IRF3 signalling pathway to activate the NLRP3 inflammasome, and subsequently increases pro‐inflammatory macrophage polarisation and decreases plaque stability to accelerate the development of atherosclerosis.
Fang Zhao   +9 more
wiley   +1 more source

A standardized approach for the isolation of vascular smooth muscle cells from carotid atherosclerotic plaques. [PDF]

open access: yesSci Rep
Byun JH   +10 more
europepmc   +1 more source

Periodontitis Exacerbates Bone Destruction in Rheumatoid Arthritis Through Porphyromonas gingivalis‐Induced Carbamylated Neutrophil Extracellular Traps

open access: yesCell Proliferation, EarlyView.
Porphyromonas gingivalis in periodontal pockets can ectopically colonize the joint cavity through the blood circulation, stimulate RA‐FLSs to release IL‐8 and induce neutrophil chemotaxis to form NETs containing carbamylated proteins. Then, cNETs upregulate the secretion of RANKL by RA‐FLSs via the MAPK signalling pathway, which consequently promotes ...
Miao Yu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy